Outset Medical, Inc. (OM) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 554 transactions totaling $874.7M, demonstrating a bearish sentiment with -$872.3M in net insider flow. The most recent transaction on Feb 17, 2026 involved a sale of 1,817 shares valued at $6.1K.
No significant insider buying has been recorded for OM in the recent period.
No significant insider selling has been recorded for OM in the recent period.
Based on recent SEC filings, insider sentiment for OM is bearish with an Insider Alignment Score of 0/100 and a net flow of -$872.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Outset Medical, Inc. (OM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading OM stock, having executed 554 transactions in the past 90 days. The most active insider is Pincus Llc Warburg (Executive), who has made 8 transactions totaling $411.2M.
Get notified when executives and directors at OM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Nash Marc | EVP Operations R&D & Service | Sale | 1,817 | $3.35 | $6.1K | |
| Feb 17, 2026 | Trigg Leslie | Executive | Sale | 3,361 | $3.35 | $11.3K | |
| Feb 17, 2026 | L. Brottem John | General Counsel | Sale | 2,842 | $3.35 | $9.5K | |
| Jan 21, 2026 | L. Brottem John | General Counsel | Sale | 1,180 | $5.01 | $5.9K | |
| Jan 21, 2026 | Nash Marc | EVP Operations R&D & Service | Sale | 980 | $4.98 | $4.9K | |
| Jan 21, 2026 | Trigg Leslie | Executive | Sale | 2,120 | $5.05 | $10.7K | |
| Jan 20, 2026 | L. Brottem John | General Counsel | Sale | 9,314 | $5.12 | $47.7K | |
| Jan 20, 2026 | Nash Marc | EVP Operations R&D & Service | Sale | 5,375 | $5.12 | $27.5K | |
| Jan 20, 2026 | Trigg Leslie | Executive | Sale | 11,794 | $5.12 | $60.4K | |
| Jan 7, 2026 | Nash Marc | EVP Operations R&D & Service | Sale | 108 | $4.27 | $461 | |
| Jan 7, 2026 | Trigg Leslie | Executive | Sale | 1,795 | $4.27 | $7.7K | |
| Jan 7, 2026 | L. Brottem John | General Counsel | Sale | 224 | $4.27 | $956 | |
| Dec 1, 2025 | Drexler Karen | Executive | Sale | 1,548 | $4.37 | $6.8K | |
| Nov 17, 2025 | L. Brottem John | Executive | Sale | 388 | $4.60 | $1.8K | |
| Nov 17, 2025 | Nash Marc | Executive | Sale | 247 | $4.60 | $1.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 303 | $873.5M | 99.3% |
Exercise(M) | 140 | $5.0M | 0.6% |
Purchase(P) | 7 | $1.2M | 0.1% |
Payment(F) | 2 | $209.0K | 0.0% |
Other(J) | 1 | $4.2K | 0.0% |
Award(A) | 95 | $0 | 0.0% |
Conversion(C) | 6 | $0 | 0.0% |
Insider selling pressure at Outset Medical, Inc. has increased, with 21 insiders executing 554 transactions across all time. Total sales of $873.5M significantly outpace purchases of $1.2M, resulting in a net outflow of $872.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.